-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Heron Therapeutics, Inc. /De/ annual/quarterly Nonoperating Income (Expense) history and growth rate from Q1 2014 to Q4 2020.
- Heron Therapeutics, Inc. /De/ Nonoperating Income (Expense) for the quarter ending December 31, 2020 was -$985K, a 168% decline year-over-year.
- Heron Therapeutics, Inc. /De/ Nonoperating Income (Expense) for the twelve months ending December 31, 2020 was $885K, a 85.1% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Nonoperating Income (Expense) for 2023 was $56K.
- Heron Therapeutics, Inc. /De/ annual Nonoperating Income (Expense) for 2022 was -$7.37M, a 158% decline from 2021.
- Heron Therapeutics, Inc. /De/ annual Nonoperating Income (Expense) for 2021 was -$2.86M, a 423% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)